José Tuells

Prof. José Tuells

Professor University of Alicante
orcid
Professor Universidad CEU Cardenal Herrera

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2010 in Vaccine
Verified
Journal Article
Closed access
Pawel StefanoffPawel Stefanoff
Pawel Stefanoff
SMSvenn-Erik Mamelund
Svenn-Erik Mamelund
MRMary Robinson
Mary Robinson
ENEva Netterlid
Eva Netterlid
José TuellsJosé Tuells
José Tuells
JYJoanne Yarwood
Joanne Yarwood

1 July 2020 in Gaceta Sanitaria
Verified
Journal Article
Open access
ANAndreu Nolasco
Andreu Nolasco
CBCarmen Barona
Carmen Barona
NTNayara Tamayo-Fonseca
Nayara Tamayo-Fonseca
MIMaría Ángeles Irles
María Ángeles Irles
RMRosa Más
Rosa Más
PPPamela Pereyra-Zamora
Pamela Pereyra-Zamora
To describe the psychometric properties and the level of understanding of the health literacy questionnaire HLS-EU-Q16 in Spanish, implemented in the Health Survey of the Valencian Region (Spain) of 2016. Descriptive cross-sectional study to describe understanding, reliability, structure and internal consistency of the questionnaire on a sample of 5485 subjects, aged 15 or over, who participated in the survey. The percentages of understanding without much difficulty were high. Reliability was high (intraclass correlation coefficient:.923; kappa:.814). The factorial analysis suggested a unifactorial structure (79.1% of variability explained by the common factor), with high factorial loads. The consistency was high (Cronbach's alpha: 0.982). The HLS-EU-Q16 in Spanish is a short, adequate and valid instrument to measure the level of health literacy in the population.

NOELIA RODRIGUEZNOELIA RODRIGUEZ
NOELIA RODRIGUEZ
Sergio Montero-NavarroSergio Montero-Navarro
Sergio Montero-Navarro
JBJose Martin Botella-Rico
Jose Martin Botella-Rico
AFAntonio J. Felipe-Gómez
Antonio J. Felipe-Gómez
Jesús Sánchez MásJesús Sánchez Más
Jesús Sánchez Más
José TuellsJosé Tuells
José Tuells
Vaccine hesitancy has increased in the past few years, influenced by the socio-cultural differences, political populism, or concerns related to the effectiveness and safety of some vaccines, resulting a feeling of distrust. This feeling can become a barrier against the achievement of the immunity necessary to stop the expansion of COVID-19. The aim of this study was to evaluate the acceptance of the vaccine against COVID-19 in Spain, as well as to identify the factors that have an influence on the concerns and attitudes of people against accepting the vaccine in the months prior to the start of vaccination on December 2020. An online questionnaire was created to obtain information about (1) sociodemographic characteristics; (2) concerns and sources of information about vaccines; and (3) attitudes about vaccination and state of health. A multivariate logistic regression was performed to identify the influencing factors. Of the 2501 participants, 1207 (48.3%) would accept the COVID-19 vaccine, 623 (24.9%) were hesitant, and 671 (26.8%) would reject it. The logistic regression showed that being male, older than 60, married, retired, with a high level of education, or with a leftist political inclination, could increase the probability of accepting the COVID-19 vaccine. Disinformation and the lack of political consensus were the main sources of distrust. The patients with hypertension, immunodepression, hypercholesterolemia, or respiratory disease, or were overweight, showed a greater acceptance to the vaccine, while those with cancer took the longest to accept it. A low acceptance of the vaccine against COVID-19 was observed among the Spanish population in the phase prior to its availability, and the main fears of the population were identified. It is necessary to offer correct and transparent information about these vaccines to reduce the concerns and increase the trust of the population, to thereby guarantee the success of the vaccination campaigns.

28 October 2022 in Archives of Medical Research
Verified
Journal Article
Open access
José TuellsJosé Tuells
José Tuells
Andrés Henao-MartinezAndrés Henao-Martinez
Andrés Henao-Martinez
Carlos Franco-ParedesCarlos Franco-Paredes
Carlos Franco-Paredes
Despite the availability of a safe and effective vaccine, yellow fever remains a major vaccine-preventable disease in endemic regions. Additionally, travelers risk acquiring yellow fever when visiting areas of endemic transmission or locations with ongoing outbreaks. Yellow fever is a viral hemorrhagic fever that has inflicted stigma, illness, and death among human societies. From the 17th to the 19th centuries, yellow fever remained a mysterious illness that predominantly affected tropical regions in Africa, the Caribbean and the Americas. The disease was as feared as cholera or smallpox, and played a significant geopolitical role in shaping modern societies. Epidemics of yellow fever brought out the best and the worst of human nature: the disease spread to new regions during the Atlantic slave trade; while the identification of its causative viral agent and mode of transmission, as well as the development of a vaccine, were made possible by the sacrifice of selfless scientists. Confirmation of the vector transmission of YF paved the way for the development of an effective vaccine in the first half of the 20th century. Encroachment of human settlements into locations with sylvatic transmission has blurred the distinction between the urban and sylvatic cycles. Introduction or expansion of routine immunization activities and reaching hard-to-reach populations consitute public health priorities toward ensuring vaccine equity in endemic areas. It is also critical to ensure the timely immunization of at-risk populations during outbreaks and to promote vaccination of international travelers. We conclude that the threat of YF will linger far into the 21st century as a leading public health emergency of global concern under the International Health Regulations.

21 November 2016 in BMC Public Health
Verified
Journal Article
Open access
PDF file
Rafael Vila CandelRafael Vila Candel
Rafael Vila Candel
PNP. Navarro-Illana
P. Navarro-Illana
ENEsther Navarro-Illana
Esther Navarro-Illana
ECEnrique Castro-Sánchez
Enrique Castro-Sánchez
KDKiri Duke
Kiri Duke
JDJAVIER DIEZ DOMINGO
JAVIER DIEZ DOMINGO
In most countries the coverage of seasonal influenza vaccination in pregnant women is low. We investigated the acceptance, reasons for rejection and professional involvement related to vaccine information in pregnant women in Valencia, Spain. Observational retrospective study in 200 pregnant women, 100 vaccinated and 100 unvaccinated, were interviewed during the 2014/2015 vaccination campaign. Electronic medical records, immunization registry and telephone interviews were used to determine reasons for vaccination and immunization rejection. 40.5% of pregnant women in the health department were vaccinated. The midwife was identified as source of information for 89% of women. The vaccine was rejected due to low perceptions of risk of influenza infection (23%), lack of information (19%), considering the vaccine as superfluous (16%), close proximity of delivery date (13%) and fear of side effects (12%). Pregnant women in Spain declined to be vaccinated due to under-estimation of the risk of contracting or being harmed by influenza, and lack of information. Interventions aiming to optimize vaccination coverage should include information addressing the safety and effectiveness of the current vaccine together with improved professional training and motivation.

4 November 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
JCJose M. Comeche
Jose M. Comeche
Pablo CaballeroPablo Caballero
Pablo Caballero
AGAna Gutierrez-Hervás
Ana Gutierrez-Hervás
SGSofía García-Sanjuan
Sofía García-Sanjuan
ICIris Comino
Iris Comino
José TuellsJosé Tuells
José Tuells
Inflammatory bowel disease (IBD) is a chronic disease mediated by the immune system and is characterized by inflammation of the gastrointestinal tract. One of the possible treatments for this pathology is a change in the type of diet, of which enteral nutrition (EN) is one. This study is to understand how the use of EN can affect the adult population diagnosed with IBD. We conducted a systematic review, meta-analysis, and a meta-regression. On the different databases (MEDLINE, Scopus, Cochrane, LILACS, CINAHL, WOS), we found 363 registers with an accuracy of 12% (44 registers). After a full-text review, only 30 research studies were selected for qualitative synthesis and 11 for meta-analysis and meta-regression. The variables used were Crohn’s disease activity index (CDAI), C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR). EN has been shown to have efficacy for the treatment of Crohn’s disease and is compatible with other medicines. As for the CDAI or rates of remission, there were no differences between enteral and parenteral nutrition. Polymeric formulas have shown better results with respect to the CRP. The long-term treatment could dilute the good CDAI results that are obtained at the start of the EN treatment.